Suicidal Ideation Clinical Trial
Official title:
Can a Brief Therapy Improve Pediatric Nightmares, Mental Health, and Suicidality?
NCT number | NCT06033781 |
Other study ID # | 15401 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 7, 2023 |
Est. completion date | January 1, 2026 |
The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | January 1, 2026 |
Est. primary completion date | January 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 17 Years |
Eligibility | Inclusion Criteria: - Child must be between ages of 6-17 years 11 months. - Child must report recurrent nightmares that meet Diagnostic and Statistical Manual of Mental Disorders criteria for nightmare disorder. - Child must speak and understand English at no less than a 6-year-old level. - Children on prescribed psychotropic medications must be stable for 30 days prior to enrolling. - Child must have a parent or legal guardian attend study visits with them. - Participants must have access to WIFI/phone data in order to participate in this study and must have an electronic device with a camera enabled. Exclusion Criteria: - Children with a diagnosis of sleep apnea which is not adequately treated. - Children whose receptive/expressive language skills are below a 6-year-old level. - If it is determined that a child is actively suicidal and at imminent risk for self-harm, the family will be notified and referred for immediate care. They will not be eligible for the study until they are deemed stable. |
Country | Name | City | State |
---|---|---|---|
United States | University of Oklahoma School of Community Medicine | Tulsa | Oklahoma |
United States | University of Tulsa | Tulsa | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
University of Oklahoma | University of Tulsa |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in reports on Sleep Journal | The sleep journal is a 3 question self report regarding nightmares. | Participants complete this daily from consent to baseline assessment (Week 0), during treatment, and before post-assessments, up to 20 weeks. They also complete a weekly version for 4 weeks following post-assessments (Weeks 10-14). | |
Primary | Change in Nightmare Disorder Diagnoses from Structure Clinical Interview for Sleep Disorders in Children (SCISD-Kid) | The SCISD-Kid is a structured clinical interview that assesses for sleep disorders. The main module interest is the nightmare disorder module. | Participants will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks. | |
Primary | Change on the Columbia Suicide Severity Rating Scale (C-SSRS) | The C-SSRS is a yes/no questionnaire to assess for suicidal ideations and behaviors. For this study, we will be looking at the 5 suicidal ideation questions. | Participants will be assessed at baseline (Week 0), at post-assessments, up to 20 weeks, and weekly following their post-assessment for 4 weeks. | |
Primary | Change on the Strengths and Difficulties Questionnaire (SDQ) - Caregiver Version | The SDQ is a 25-item brief behavioral screening questionnaire for detecting mental health problems in general populations people aged 2-17. It assesses three scales for internalizing problems (10 items), externalizing problems (10 items), and prosocial behavior (5 items). The internalizing and externalizing scales have scores ranging from 0 to 20 with higher scores indicating more difficulties. The prosocial behavior scale ranges from 0 to 10 with higher scores indicating more prosocial behaviors. | Participants' caregivers will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks. | |
Primary | Change on the Patient Health-Questionnaire-9 (PHQ-9) | The PHQ-9 is a 9-question Likert scale questionnaire to assess for depression. The items are scored on a scale of 0-27. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe, and severe depression, respectively. | Participants will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks. | |
Secondary | Change on the Child Adolescent Trauma Screen (CATS) - Child Version | The CATS screens for child trauma history and PTSD symptoms in youth ages 7-17; 15 YES/NO questions; 1 open-ended question | Participants will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks. | |
Secondary | Change on the Patient Health-Questionnaire-2 (PHQ-2) | The PHQ-9 is a 2-question Likert scale questionnaire to screen for depression. Scores range from 0-6. A score of 3 or greater indicates major depressive disorder may exist. | Participants will be assessed at baseline (Week 0), at post-assessments, up to 20 weeks, and weekly following their post-assessment for 4 weeks. | |
Secondary | Change on the Child Adolescent Trauma Screen (CATS) - Caregiver Version | The CATS screens for child trauma history and PTSD symptoms in youth ages 7-17; 15 YES/NO questions; 1 open-ended question | Participants' caregivers will be assessed at baseline (Week 0) and at post-assessments, up to 20 weeks. | |
Secondary | Change on Sleep Locus of Control (SLOC) | The SLOC is a 5 item self report measure perceived contingencies between sleep behavior and events. This scale is collected as a child self report, and a caregiver report regarding child. The items are answered with a 1-5 Likert scale with total scores ranging from 5 to 25. Higher scores indicate higher locus of control. | Participants and caregivers will be assessed at Baseline (Week 0), post-assessments, and weekly during therapy, up to 20 weeks. | |
Secondary | Change on Nightmare Locus of Control (NLOC) | The NLOC is a 5 item self report measure regarding nightmare behavior and events. This scale is collected as a child self report, and a caregiver report regarding child. The items are answered with a 1-5 Likert scale with total scores ranging from 5 to 25. Higher scores indicate higher locus of control. | Participants and caregivers will be assessed at Baseline (Week 0), post-assessments, and weekly during therapy, up to 20 weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05334381 -
Navigating Mental Health Treatment for Black Youth
|
N/A | |
Recruiting |
NCT04653337 -
Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression
|
Phase 2 | |
Terminated |
NCT04254809 -
Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts
|
N/A | |
Recruiting |
NCT05848089 -
Real-time Intervention for Suicide Risk Reduction
|
N/A | |
Recruiting |
NCT06322199 -
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
|
||
Completed |
NCT05280756 -
Home-based tDCS for Prevention of Suicidal Ideation
|
N/A | |
Not yet recruiting |
NCT06454136 -
Pilot Trial of Mobile Technology for Adolescent Suicidality
|
N/A | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Completed |
NCT02021344 -
Mental Health First Aid for College Students
|
N/A | |
Not yet recruiting |
NCT04686162 -
Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy
|
N/A | |
Recruiting |
NCT05377177 -
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
|
N/A | |
Completed |
NCT05580757 -
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
|
||
Recruiting |
NCT05925322 -
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
|
N/A | |
Not yet recruiting |
NCT05427734 -
Treating Drivers of Suicide Using Jaspr Health
|
N/A | |
Recruiting |
NCT04112368 -
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
|
Phase 4 | |
Completed |
NCT04026308 -
Written vs Electronic Safety Planning Study
|
N/A | |
Recruiting |
NCT05537376 -
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
|
N/A | |
Not yet recruiting |
NCT06311591 -
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B
|
N/A | |
Recruiting |
NCT05894980 -
How to Reduce Suicidal Thoughts and Impulsivity in Depression
|
N/A | |
Not yet recruiting |
NCT05860257 -
Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction
|
N/A |